Samodzielny Publiczny Zaklad Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego W Lodzi

At Samodzielny Publiczny Zaklad Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego W Lodzi, clinical trials in cardiovascular diseases focus on major conditions such as acute coronary syndrome, atrial fibrillation, heart failure, and hypertension. The research is aimed at improving event prevention, supporting better symptom control, and evaluating new treatment strategies for people at high cardiovascular risk.

• Reducing the risk of heart attacks, stroke, and other major cardiovascular events
• Improving treatment options for atrial fibrillation and related clotting risk
• Studying therapies for heart failure, including worsening and acute forms

These studies reflect a strong interest in practical advances that may help lower complications and improve long-term outcomes in patients with serious heart and blood vessel disease.

This site conducts extensive research in renal diseases and immune system disorders, especially IgA nephropathy, lupus nephritis, membranous nephropathy, and other chronic kidney conditions. Many trials are designed to test new therapies that may slow kidney damage, reduce proteinuria, and preserve kidney function over time.

• Evaluating treatments for IgA nephropathy and other glomerular diseases
• Studying approaches to slow chronic kidney disease progression
• Testing therapies for lupus nephritis and related autoimmune kidney involvement

The research portfolio also includes work on kidney-related symptoms and complications, showing a broad effort to improve both disease control and everyday quality of life.

Clinical trials in digestive system diseases at this hospital cover ulcerative colitis and Crohn’s disease, with a particular emphasis on moderate to severe disease in both adults and children. The main purpose is to assess new and established therapies that may improve remission rates, maintain disease control, and reduce inflammatory burden.

• Testing treatments for ulcerative colitis and Crohn’s disease
• Exploring options for pediatric and adult inflammatory bowel disease care
• Evaluating therapies intended to improve remission and long-term disease management

These studies support ongoing efforts to offer more effective and better-tolerated care for people living with chronic intestinal inflammation.

The site also participates in research on blood diseases and neoplasms, including acute lymphoblastic leukemia and lymphoblastic lymphoma. The trials are focused on improving survival, reducing relapse, and refining treatment approaches for children and adolescents with aggressive blood cancers.

• Studying treatment strategies for acute lymphoblastic leukemia
• Investigating care for lymphoblastic lymphoma
• Aiming to improve remission outcomes and reduce treatment-related complications

This area highlights the center’s role in pediatric and adolescent cancer research, with an emphasis on better disease control and safer care.

Research in nervous system diseases and mental disorders includes trials in Alzheimer’s disease, schizophrenia, depression, anxiety, and attention-deficit hyperactivity disorder. These studies are designed to assess new options for symptom relief, cognitive support, and long-term safety in patients with complex brain and mental health conditions.

• Evaluating therapies for Alzheimer’s disease and mild cognitive impairment
• Studying treatment approaches for schizophrenia and treatment-resistant symptoms
• Exploring care for depression, anxiety, and related psychiatric conditions

These trials show a broad commitment to advancing both neurological and psychiatric care through improved treatment effectiveness and safety.

The research program includes several studies in autoimmune diseases, musculoskeletal diseases, and congenital conditions, such as juvenile psoriatic arthritis, systemic lupus erythematosus, hereditary angioedema, and osteogenesis imperfecta. The focus is on testing therapies that may improve disease control, reduce symptoms, and support safer long-term management in younger patients.

• Testing treatments for juvenile psoriatic arthritis and other pediatric inflammatory disorders
• Studying immune-targeted therapies for systemic lupus erythematosus
• Evaluating new options for hereditary angioedema and osteogenesis imperfecta

At the Lodz site, these trials add an important pediatric and autoimmune dimension to the broader clinical research portfolio.

Additional trials cover nutritional and metabolic diseases, respiratory tract diseases, bacterial infections, and other internal medicine conditions. Key areas include type 2 diabetes, obesity, asthma, and complicated urinary infections, with research aimed at improving treatment effectiveness and disease control.

• Assessing therapies for type 2 diabetes and metabolic risk
• Studying interventions for asthma and other respiratory conditions
• Evaluating treatment options for complicated urinary tract infections and other infections

These studies show the site’s wide clinical reach beyond cardiology, supporting research across common chronic illnesses and acute medical problems.